Akebia Therapeutics Inc. (AKBA) Statistics & Valuation Metrics - Stocknear

Akebia Therapeutics Inc.

NASDAQ: AKBA · Real-Time Price · USD
2.74
0.03 (1.11%)
At close: Sep 26, 2025, 3:59 PM
2.76
0.71%
After-hours: Sep 26, 2025, 07:54 PM EDT

Akebia Therapeutics Statistics

Share Statistics

Akebia Therapeutics has 265.15M shares outstanding. The number of shares has increased by 24.89% in one year.

265.15M
24.89%
0.54%
40.53%
259.8M
18,382
0.48%

Short Selling Information

The latest short interest is 27.36M, so 10.32% of the outstanding shares have been sold short.

27.36M
10.32%
10.43%
7.09

Valuation Ratios

The PE ratio is -5.77 and the forward PE ratio is 33.88. Akebia Therapeutics's PEG ratio is -0.32.

-5.77
33.88
2.5
2.5
-8.15
-9.85
-0.32
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Akebia Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 1.41, with a Debt / Equity ratio of -0.97.

1.41
1.21
-0.97
-3.47
-1.17
-2.78

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$884.97K
$-383.48K
181
0.73
3.89

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by 106.02% in the last 52 weeks. The beta is 1.02, so Akebia Therapeutics's price volatility has been higher than the market average.

1.02
106.02%
3.24
2.65
37.68
3,801,657

Income Statement

In the last 12 months, Akebia Therapeutics had revenue of 160.18M and earned -69.41M in profits. Earnings per share was -0.33.

160.18M
97M
-50.47M
-69.41M
-13.72M
-51.23M
-0.33
Full Income Statement

Balance Sheet

The company has 51.87M in cash and 47.64M in debt, giving a net cash position of 4.23M.

51.87M
47.64M
4.23M
-1.68B
345.6M
115.94M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -40.66M and capital expenditures -33K, giving a free cash flow of -40.69M.

-40.66M
-33K
-40.69M
-0.19
Full Cash Flow Statement

Margins

Gross margin is 60.56%, with operating and profit margins of -31.51% and -43.33%.

60.56%
-31.51%
-43.33%
-43.33%
-8.57%
-31.51%
-25.4%

Dividends & Yields

AKBA does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for AKBA is $6.5, which is 137.2% higher than the current price. The consensus rating is "Buy".

$6.5
137.2%
Buy
4
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-4.39
5